- Home
- OKYO
OKYO
OKYO Pharma Limited
as of 12-19-2025 3:57pm EST
$2.04
+$0.17
+9.09%
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Chart Type:
Time Range:
| Founded: | 2007 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 79.7M | IPO Year: | 2022 |
| Target Price: | $6.00 | AVG Volume (30 days): | 167.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.90 - $3.35 | Next Earning Date: | 07-18-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered OKYO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 21 hours ago
AI Recommendation
hold
Model Accuracy: 73.29%
73.29%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest OKYO Pharma Limited News
OKYO Breaking Stock News: Dive into OKYO Ticker-Specific Updates for Smart Investing
GlobeNewswire
OKYO Pharma Announces Chairman and Founder Acquires Shares
📈
AI Sentiment
Highly Positive
8/10
Compare OKYO vs Leading Stocks
See how OKYO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OKYO OKYO Pharma Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.